Procedural and follow-up outcomes among patients undergoing successful recanalisation of coronary chronic total occlusions using biolimus drug-eluting stents.

about

Procedural and follow-up outcomes among patients undergoing successful recanalisation of coronary chronic total occlusions using biolimus drug-eluting stents.

Item

http://www.wikidata.org/entity/Q53634713

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@en

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@nl

type

Item

label

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@en

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@nl

prefLabel

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@en

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@nl

P1476

Procedural and follow-up outco ...... biolimus drug-eluting stents.

@en

P2093

D Hildick-Smith

http://www.w3.org/2001/XMLSchema#string

I Ferreira

http://www.w3.org/2001/XMLSchema#string

J Cockburn

http://www.w3.org/2001/XMLSchema#string

S Hopkins

http://www.w3.org/2001/XMLSchema#string

S Saraf

http://www.w3.org/2001/XMLSchema#string

P2860

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.

Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).

Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents.

Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE program.

Long-term clinical and angiographic results of Sirolimus-Eluting Stent in Complex Coronary Chronic Total Occlusion Revascularization: the SECTOR registry.

Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.

P2888

s12928-014-0243-y

P304

216-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12928-014-0243-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24452923

http://www.w3.org/2001/XMLSchema#string